Health Products Type I ? Class 1/Type I = High risk (serious health hazard). Class 2/Type II = Moderate risk. Class 3/Type III = Low risk. Updated 2024-06-06

Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

See all recalls from Mint-Betahistine →
Share: Facebook X / Twitter WhatsApp

Recalled Product

Mint-Betahistine 8, 16 & 24mg


✅ What Should You Do?

  1. 🛑 Stop using this product immediately and set it aside.
  2. Return the affected products to your local pharmacy for a replacement, and for proper disposal.
  3. 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
  4. 📋 Report an adverse reaction to Health Canada MedEffect
Looking for a safe alternative? Search Amazon Canada for Mint-Betahistine 8, 16 →

Hazard / Issue

Product quality

Issued by

Drugs and health products

⚠️ What You Should Do

Return the affected products to your local pharmacy for a replacement, and for proper disposal. If you are unsure whether your product is affected, check with your pharmacy.Consult a health care professional if you have used the affected product and you have health concerns.Report any health product-related side effects or complaints to Health Canada.Contact the companies if you have questions about their recall:Accel Pharma Inc., by contacting Betty Cory at Accel Quality Assurance by calling 416-271-4775, or by email at bcory@regxia.comMint Pharmaceuticals Inc., by contacting Olenka Crewe at Mint Pharmaceuticals Inc. Scientific Affairs by calling 416-803-9151, or by email at olenkac@mintpharmaceuticals.comPharmascience Inc. by calling, toll-free, at 1-800-340-9735, or by email at customercarePms@pharmascience.com
View official government recall